Dyskinesia in Parkinson's Disease Therapy

Dyskinesia in Parkinson's Disease Therapy

Bibliographic Details
Main Authors:	Anna Rosa Carta, Andrea Giuffrida, Gilberto Fisone
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2012/639080

Similar Items

Foetal Cell Transplantation for Parkinson’s Disease: Focus on Graft-Induced Dyskinesia
by: Elisabetta Tronci, et al.
Published: (2015-01-01)

Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
by: José Fidel Baizabal-Carvallo, et al.
Published: (2021-09-01)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
by: John C. P. Piedad, et al.
Published: (2012-01-01)

Surgical Treatment of Dyskinesia in Parkinson’s Disease
by: Renato Puppi Munhoz, et al.
Published: (2014-04-01)

Rhabdomyolysis Related to Dyskinesia in Parkinson’s Disease
by: Hesna Bektaş, et al.
Published: (2014-04-01)

Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease
by: Eunju Shin, et al.
Published: (2012-09-01)

Parkinson's disease: carbidopa, nausea, and dyskinesia
by: Hinz M, et al.
Published: (2014-11-01)

Pharmacogenetics of drug-induced dyskinesias in Parkinson's disease
by: A. A. Tappakhov, et al.
Published: (2020-02-01)

PET studies in Parkinson's disease dyskinesias and dementia
by: Ahmed, Imtiaz
Published: (2012)

Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease
by: Eunju Shin, et al.
Published: (2012-01-01)

Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)

Future Scenarios for Levodopa-induced Dyskinesias in Parkinson’s disease
by: Antonio eCerasa, et al.
Published: (2015-04-01)

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China
by: Xun Zhou, et al.
Published: (2019-05-01)

Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
by: Han Soo Yoo, et al.
Published: (2019-11-01)

Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease
by: E.L. Lane, et al.
Published: (2008-11-01)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
by: Hinz M, et al.
Published: (2021-03-01)

5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
by: Elisabetta Tronci, et al.
Published: (2013-12-01)

Abnormal cortical facilitation and L-dopa-induced dyskinesia in Parkinson's disease
by: Andrea Guerra, et al.
Published: (2019-11-01)

A2A Receptor Antagonism and Dyskinesia in Parkinson’s Disease
by: Micaela Morelli, et al.
Published: (2012-01-01)

Striatal neurons in the development of levodopa-induced dyskinesias in Parkinson’s disease
by: Alberico, Stephanie Lorraine
Published: (2017)

Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01)

Levodopa-induced dyskinesias in Parkinson’s disease: emerging treatments
by: Bargiotas P, et al.
Published: (2013-10-01)

Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial.
by: Hideyuki Sawada, et al.
Published: (2010-01-01)

Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?
by: Paolo Calabresi, et al.
Published: (2019-12-01)

Persistent dyskinesias in patients with fetal tissue transplantation for Parkinson disease
by: Paul E. Greene, et al.
Published: (2021-04-01)

Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's Disease.
by: D Tomas, et al.
Published: (2016-01-01)

Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson’s Disease
by: J. Guridi, et al.
Published: (2012-01-01)

Implication of the serotoninergic systems in Parkinson's disease and L-Dopa-induced dyskinesia
by: Riahi, Golnasim
Published: (2012)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

Exome-wide association study of levodopa-induced dyskinesia in Parkinson’s disease
by: Eva König, et al.
Published: (2021-10-01)

Manual tracking in Parkinson's disease : implications for L-dopa-induced dyskinesias
by: Stevenson, James
Published: (2011)

White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson’s disease
by: Seok Jong Chung, et al.
Published: (2020-02-01)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
by: Tianbin Song, et al.
Published: (2021-03-01)

Levodopa-induced Dyskinesias in Parkinson's Disease: Current Knowledge and Future Scenarios
Published: (2015)

Implication of the serotoninergic systems in Parkinson's disease and L-Dopa-induced dyskinesia
by: Riahi, Golnasim
Published: (2012)

Early Dyskinesias in Parkinson’s Disease Patients With Parkin Mutation: A Primary Corticostriatal Synaptopathy?
by: Jenny Sassone, et al.
Published: (2019-03-01)

Multivariable clinical-genetic model for predicting dyskinesia in early-onset Parkinson’s disease
by: Yong-Ping Chen, et al.
Published: (2021-07-01)

Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson's disease.
by: Jin Yong Hong, et al.
Published: (2020-01-01)

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia
by: Changwei Yang, et al.
Published: (2020-03-01)

Cannot write session to /tmp/vufind_sessions/sess_e8r6f4jm0cskfd60ill5phr0ll